TL;DR: A 2026 randomized trial in Nature and Science of Sleep found that Sancai acupoint acupuncture reduced primary-insomnia severity more than sham acupuncture, with parallel improvements in sleep testing and peripheral 5-HT and BDNF biomarkers. Key Findings 76-person insomnia trial: Researchers randomized 38 patients to real Sancai acupuncture and 38 to sham acupuncture. 20 treatment …
TL;DR: A 2026 preprint in medRxiv linked recurrent major depression to direction-specific effective-connectivity changes, with strongest patterns in cerebellar-cortical, sensorimotor, cognitive, neurotransmitter, and oligodendrocyte precursor cell maps. Key Findings 1,627-person discovery dataset: REST-meta-MDD resting-state functional MRI (fMRI) and T1 MRI data compared 839 people with major depression and 788 controls. Recurrent depression pattern: First-episode drug-naive …
TL;DR: A 2026 study in BJPsych Open found that closely monitored antidepressant care improved quality of life and reduced societal costs in both PReDicT and usual-care groups, while the PReDicT algorithm added uncertain, country-dependent economic value. Key Findings Multinational trial data anchored the analysis: The economic evaluation followed 913 patients in France, Germany, the Netherlands, …
TL;DR: A 2026 study in Radiology Case Reports described a 14-year-old boy whose seizure workup found a rare congenital left parahippocampal herniation on MRI, with imaging features that favored a benign developmental variant rather than tumor or acute brain herniation. Key Findings One adolescent case: The report involved a previously healthy 14-year-old boy evaluated after …
TL;DR: A 2026 systematic review and meta-analysis in Journal of Sleep Research found that agomelatine modestly improved subjective sleep quality versus placebo, but objective total sleep time did not significantly increase and somnolence reports were more frequent. Key Findings 25 RCTs: The review included 25 double-blind randomized controlled trials with 6,812 randomized participants. Subjective sleep …
TL;DR: A 2026 review in Neuropsychiatric Disease and Treatment argues that miR-425-3p is a candidate depression biomarker because it connects stress biology, MAPK/Wnt signaling, inflammation, and antidepressant response evidence. Key Findings 280 million MDD burden: The review opens from the scale of major depressive disorder, which affects more than 280 million people worldwide. About 20-fold …
TL;DR: A 2026 study in Interactive Journal of Medical Research used structured hospital records plus natural language processing of clinical notes to profile major depressive disorder in Belgium, finding that 46% of 1,147 adults met a real-world treatment-resistant depression definition. Key Findings Belgian EHR cohort: The retrospective study drew from 1,147 adults with major depressive …
TL;DR: A 2026 preprint posted on medRxiv found that iSupport-Malaysia, a culturally adapted multimedia dementia-caregiver platform, scored above the usual usability benchmark and was viewed as culturally appropriate by caregivers and healthcare professionals. Key Findings Four-phase adaptation: The WHO iSupport dementia program was translated into Bahasa Malaysia, culturally adapted, and rebuilt as multimedia e-learning. 23 …
TL;DR: A 2025 mouse study in eNeuro reported that inhaled cannabidiol reduced IDO and cGAS pathway activity and lowered pro-inflammatory cytokines in male 5XFAD Alzheimer’s model mice. Key Findings 5XFAD model: The study used male 5XFAD transgenic mice, a common amyloid-heavy Alzheimer’s disease model. Inhaled CBD: Cannabidiol was administered by inhalation rather than by oral …
TL;DR: A 2026 study in iScience found that migraine patients with patent foramen ovale had altered plasma metabolic profiles, with lower indoleacrylic acid and an IA-plus-hs-CRP marker pair showing exploratory discrimination in a validation cohort. Key Findings 30 discovery patients: Untargeted metabolomics compared 30 migraine patients with patent foramen ovale against 17 matched controls. 4,858 …
